Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy: clinical commentary.
Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions.
Recovery of peripheral muscle function from fatiguing exercise and daily physical activity level in patients with multiple sclerosis: A case-control study.
Data collection capabilities of a new non-invasive monitoring system for patients with advanced multiple sclerosis.
B cells in Multiple Sclerosis: Good or bad guys?: An article for 28 May 2014 - World MS Day 2014.
Human vaccines & immunotherapeutics: news.
Medicinal cannabis.
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Generating induced pluripotent stem cells for multiple sclerosis therapy.
Proteomics of a conundrum: thoughts on addressing the aetiology vs. progression of Multiple Sclerosis.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
[Support from a non-profit organisation to improve Multiple sclerosis patients' quality of life].
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
Diagnostic ability of a new method for measuring haemoglobin levels in the optic nerve head in multiple sclerosis patients.
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis.
Proteome analysis of post-transplantation recovery mechanisms of an EAE model of multiple sclerosis treated with embryonic stem cell-derived neural precursors.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
Ultrasound detection of knee joint degeneration in patients with multiple sclerosis.
Pages
« first
‹ previous
…
515
516
517
518
519
520
521
522
523
…
next ›
last »